Terms: = Cervical cancer AND CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1
11 results:
1. Genetic Polymorphisms of Cytochromes P450 in Finno-Permic Populations of Russia.
Dzhaubermezov M; Ekomasova N; Mustafin R; Gabidullina L; Galimova Y; Nurgalieva A; Valova Y; Prokofyeva D; Khusnutdinova E
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553620
[TBL] [Abstract] [Full Text] [Related]
2. Pharmacogenetics as a predictor chemotherapy induced peripheral neuropathy in gynecologic cancer patients treated with Taxane-based chemotherapy.
Mysona D; Dorr K; Ward A; Shaver E; Rungruang B; Ghamande S
Gynecol Oncol; 2023 Jan; 168():114-118. PubMed ID: 36434945
[TBL] [Abstract] [Full Text] [Related]
3. cyp2d6 and CYP2E1 Gene Polymorphisms and their Association with cervical cancer Susceptibility: A Hospital Based Case-Control Study from South-Western Maharashtra.
Datkhile KD; Durgawale PP; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2591-2597. PubMed ID: 36037111
[TBL] [Abstract] [Full Text] [Related]
4. CYP1A1 and cyp2d6 gene polymorphisms in Israeli Jewish women with cervical cancer.
Gutman G; Morad T; Peleg B; Peretz C; Bar-Am A; Safra T; Grisaru D
Int J Gynecol Cancer; 2009 Nov; 19(8):1300-2. PubMed ID: 20009880
[TBL] [Abstract] [Full Text] [Related]
5. Allelic variations in cyp2d6 gene and susceptibility to cervical cancer.
Wajid S; Naqvi SH; Juneja A; Bharadwaj M; Mitra AB
Drug Metab Lett; 2007 Dec; 1(4):276-80. PubMed ID: 19356055
[TBL] [Abstract] [Full Text] [Related]
6. HLA genes and other candidate genes involved in susceptibility for (pre)neoplastic cervical disease.
Zoodsma M; Nolte IM; Te Meerman GJ; De Vries EG; Van der Zee AG
Int J Oncol; 2005 Mar; 26(3):769-84. PubMed ID: 15703836
[TBL] [Abstract] [Full Text] [Related]
7. Cytochrome P450 gene polymorphism and cancer.
Agundez JA
Curr Drug Metab; 2004 Jun; 5(3):211-24. PubMed ID: 15180491
[TBL] [Abstract] [Full Text] [Related]
8. cyp2d6 genotype and the incidence of anal and vulvar cancer.
Chen C; Cook LS; Li XY; Hallagan S; Madeleine MM; Daling JR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):317-21. PubMed ID: 10207635
[TBL] [Abstract] [Full Text] [Related]
9. Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 cyp2d6.
Worrall SF; Corrigan M; High A; Starr D; Matthias C; Wolf CR; Jones PW; Hand P; Gilford J; Farrell WE; Hoban P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Oct; 8(5):433-9. PubMed ID: 9825835
[TBL] [Abstract] [Full Text] [Related]
10. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, cyp2d6 and smoking.
Warwick A; Sarhanis P; Redman C; Pemble S; Taylor JB; Ketterer B; Jones P; Alldersea J; Gilford J; Yengi L
Carcinogenesis; 1994 Dec; 15(12):2841-5. PubMed ID: 8001244
[TBL] [Abstract] [Full Text] [Related]
11. Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 cyp2d6 EM and glutathione s-transferase GSTM1 null genotypes and cigarette smoking.
Warwick AP; Redman CW; Jones PW; Fryer AA; Gilford J; Alldersea J; Strange RC
Br J Cancer; 1994 Oct; 70(4):704-8. PubMed ID: 7917923
[TBL] [Abstract] [Full Text] [Related]
